Advertisement
Advertisement

PMVP

PMVP logo

PMV Pharmaceuticals, Inc

1.18
USD
Sponsored
-0.03
-2.48%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

1.21

+0.03
+2.54%

PMVP Earnings Reports

Positive Surprise Ratio

PMVP beat 14 of 22 last estimates.

64%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.40
Implied change from Q1 26 (Revenue/ EPS)
--
/
+17.65%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-2.44%

PMV Pharmaceuticals, Inc earnings per share and revenue

On May 12, 2026, PMVP reported earnings of -0.34 USD per share (EPS) for Q1 26, beating the estimate of -0.41 USD, resulting in a 18.70% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.16% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an increase of 17.65% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, PMV Pharmaceuticals, Inc reported EPS of -$0.34, beating estimates by 18.7%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.16%, changed from $1.39 before the earnings release to $1.42 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 5 analysts, PMV Pharmaceuticals, Inc is expected to report EPS of -$0.40 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement